Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes

BACKGROUND: The aim of this study was to investigate how differences in expression of HER2 between primary gastric cancers (PGCs) and their corresponding metastatic lymph nodes (LMNs) might affect its potential as a prognostic indicator in treatments including anti-HER2 agents. METHODS: The analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochi, Mitsugu, Fujii, Masashi, Masuda, Shinobu, Kanamori, Noriaki, Mihara, Yoshiaki, Funada, Tomoya, Tamegai, Hidenori, Watanabe, Megumu, Suda, Hiroshi, Takayama, Tadatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937244/
https://www.ncbi.nlm.nih.gov/pubmed/24261710
http://dx.doi.org/10.1186/1746-1596-8-191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937244/
https://www.ncbi.nlm.nih.gov/pubmed/24261710
http://dx.doi.org/10.1186/1746-1596-8-191

Ejemplares similares